IGC Pharma (IGC) Q2 2026 Earnings Report

1,055 Followers

IGC Q2 2026 EPS Results

Actual EPS-$0.02

Consensus EPS-$0.02

Beat/MissMet expectations

One Year Ago EPS-$0.02

Actual Revenue$191.00K

Expected Revenue$383.00K

Beat/MissMissed by -$192.00K

YoY Revenue Growth-53.64%

QuarterQ2 2026

Date11/17/2025

TimeBefore Open

Conference CallMonday, November 17, 2025

IGC Upcoming Earnings

IGC Pharma's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

IGC Q2 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2027 (Q2)	-0.02 / -	-0.02	―
Jun 15, 2026	2026 (Q4)	- / -0.02	-0.02	0.00% (0.00)
Mar 19, 2026	2026 (Q3)	-0.02 / -0.01	-0.02	50.00% (+0.01)
Nov 17, 2025	2026 (Q2)	-0.02 / -0.02	-0.02	0.00% (0.00)
Aug 19, 2025	2026 (Q1)	- / -	-0.03	―
Jun 30, 2025	2025 (Q4)	-0.02 / -0.02	-0.03	33.33% (<+0.01)
Feb 18, 2025	2025 (Q3)	-0.03 / -0.02	-0.09	77.78% (+0.07)
Nov 14, 2024	2025 (Q2)	-0.03 / -0.02	-0.05	60.00% (+0.03)
Aug 09, 2024	2025 (Q1)	-0.03 / -0.03	-0.039	23.08% (<+0.01)
Jun 24, 2024	2024 (Q4)	-0.04 / -0.04	-0.076	53.95% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed